Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neerja Bhatla

Showing results (221-230 of 249) with videos related to

Pageof 25
Sort By:
Vaccine|November 9, 2024
Overview of CHIC symposia series: Summary of Africa and South Asia symposiaAna Bolio, Dur-E-Nayab Waheed, Nelly Mugo, et al.
JAMA Network Open|March 2, 2022
Effects of a Lifestyle Intervention to Prevent Deterioration in Glycemic Status Among South Asian Women With Recent Gestational Diabetes: A Randomized Clinical TrialNikhil Tandon, Yashdeep Gupta, Deksha Kapoor, et al.
Preventive Medicine|December 13, 2021
Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancerNathalie Broutet, Jose Jeronimo, Somesh Kumar, et al.
The Lancet. Oncology|November 2, 2019
Current status of human papillomavirus vaccination in India's cervical cancer prevention effortsRengaswamy Sankaranarayanan, Partha Basu, Prabhdeep Kaur, et al.
Plos One|April 22, 2015
Underweight full-term Indian neonates show differences in umbilical cord blood leukocyte phenotype: a cross-sectional studyDeepak K Rathore, Deepa Nair, Saimah Raza, et al.
The Lancet. Oncology|November 10, 2023
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trialHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Vaccine|August 25, 2022
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022Holly J Prudden, Sharon L Achilles, Celina Schocken, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 23, 2024
Development of a risk prediction model for postpartum onset of type 2 diabetes mellitus, following gestational diabetes; the lifestyle InterVention in gestational diabetes (LIVING) studyYitayeh Belsti, Lisa J Moran, Rebecca Goldstein, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 19, 2019
Revised FIGO staging for carcinoma of the cervix uteriNeerja Bhatla, Jonathan S Berek, Mauricio Cuello Fredes, et al.
International Journal of Cancer|June 8, 2026
Clinical Validation of Four Point-of-Care High-Risk HPV Assays, Including Two Reduced-Valency Assays, for Cervical Cancer Screening in Low-Resource SettingsNeerja Bhatla, MaryLuz Rol, Seema Singhal, et al.
Pageof 25

Showing results (221-230 of 249) with videos related to

Sort By:
Pageof 25
Vaccine|November 9, 2024
Overview of CHIC symposia series: Summary of Africa and South Asia symposiaAna Bolio, Dur-E-Nayab Waheed, Nelly Mugo, et al.
JAMA Network Open|March 2, 2022
Effects of a Lifestyle Intervention to Prevent Deterioration in Glycemic Status Among South Asian Women With Recent Gestational Diabetes: A Randomized Clinical TrialNikhil Tandon, Yashdeep Gupta, Deksha Kapoor, et al.
Preventive Medicine|December 13, 2021
Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancerNathalie Broutet, Jose Jeronimo, Somesh Kumar, et al.
The Lancet. Oncology|November 2, 2019
Current status of human papillomavirus vaccination in India's cervical cancer prevention effortsRengaswamy Sankaranarayanan, Partha Basu, Prabhdeep Kaur, et al.
Plos One|April 22, 2015
Underweight full-term Indian neonates show differences in umbilical cord blood leukocyte phenotype: a cross-sectional studyDeepak K Rathore, Deepa Nair, Saimah Raza, et al.
The Lancet. Oncology|November 10, 2023
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trialHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Vaccine|August 25, 2022
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022Holly J Prudden, Sharon L Achilles, Celina Schocken, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 23, 2024
Development of a risk prediction model for postpartum onset of type 2 diabetes mellitus, following gestational diabetes; the lifestyle InterVention in gestational diabetes (LIVING) studyYitayeh Belsti, Lisa J Moran, Rebecca Goldstein, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 19, 2019
Revised FIGO staging for carcinoma of the cervix uteriNeerja Bhatla, Jonathan S Berek, Mauricio Cuello Fredes, et al.
International Journal of Cancer|June 8, 2026
Clinical Validation of Four Point-of-Care High-Risk HPV Assays, Including Two Reduced-Valency Assays, for Cervical Cancer Screening in Low-Resource SettingsNeerja Bhatla, MaryLuz Rol, Seema Singhal, et al.
Pageof 25